Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis

Overview of attention for article published in Drug Design, Development and Therapy, July 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

PF Warriors - Pulmonary Fibrosis, IPF, other Rare Lung Diseases, 12 Jul 2019

Differences in tolerability of pirfenidone (Esbriet) between elderly and younger patients with idiopathic pulmonary fibrosis #Cur…